Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Comment by topseekeron Jul 21, 2020 8:41pm
139 Views
Post# 31299353

RE:RE:RE:Some Free DD for the Stockhouse crowd

RE:RE:RE:Some Free DD for the Stockhouse crowd
SoulTsunami wrote: I as well feel that we need to get on with trials so that we can see facts AMG. I posted this to Stockhouse for new eyes to this story or anyone who has been misdirected by the disinformation that characterizes Stockhouse in general. Unfortunately, this is one of the first sites to pop up when you search the web for Algernon Pharmaceuticals and I wanted to ensure some form of intelligent contribution as we march forward. Today's news is definitely good and increases the odds of success from my perspective. As to my wording "Free DD", I view and budget my time like it is a currency. I was not trying to be facetious and apologize if I came off that way. The post was simply meant to provide some structured truth in order to facilitate learning from proper information, while combating misinformation and misdirection.


 Well said SoulTsunami. I find your blogs here on this site very informative/useful. Your links for eg. to interviews I find are very informative in helping me further appreciate what AGN has to offer all shareholders.

 Many thanks, and looking forward to your next blog on AGN.

 Best wishes to All, good health,

 Sincerely,

 Topseeker

<< Previous
Bullboard Posts
Next >>